×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
DYN – dyne therapeutics, inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DYN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/17
06:29 am
dyn
Dyne Therapeutics, Inc. (NASDAQ: DYN) was upgraded by analysts at Baird R W to a "strong-buy" rating.
Neutral
Report
Dyne Therapeutics, Inc. (NASDAQ: DYN) was upgraded by analysts at Baird R W to a "strong-buy" rating.
12/14
05:49 am
dyn
Dyne Therapeutics, Inc. (NASDAQ: DYN) was upgraded by analysts at Raymond James to a "strong-buy" rating.
Low
Report
Dyne Therapeutics, Inc. (NASDAQ: DYN) was upgraded by analysts at Raymond James to a "strong-buy" rating.
12/13
07:49 am
dyn
Dyne Therapeutics, Inc. (NASDAQ: DYN) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $46.00 price target on the stock.
Low
Report
Dyne Therapeutics, Inc. (NASDAQ: DYN) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $46.00 price target on the stock.
11/26
07:51 am
dyn
Dyne Therapeutics, Inc. (NASDAQ: DYN) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $45.00 price target on the stock.
Low
Report
Dyne Therapeutics, Inc. (NASDAQ: DYN) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $45.00 price target on the stock.
11/21
09:10 am
dyn
Paragon Therapeutics Appoints Susanna High as Chief Executive Officer [Yahoo! Finance]
Low
Report
Paragon Therapeutics Appoints Susanna High as Chief Executive Officer [Yahoo! Finance]
11/13
06:51 pm
dyn
Dyne Therapeutics, Inc. (NASDAQ: DYN) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $50.00 price target on the stock.
High
Report
Dyne Therapeutics, Inc. (NASDAQ: DYN) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $50.00 price target on the stock.
11/13
10:08 am
dyn
Dyne Therapeutics, Inc. (NASDAQ: DYN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.
High
Report
Dyne Therapeutics, Inc. (NASDAQ: DYN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.
11/12
07:30 am
dyn
Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Medium
Report
Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/11
08:42 pm
dyn
Form 4 Dyne Therapeutics, Inc. For: Dec 11 Filed by: Beskrovnaya Oxana
Medium
Report
Form 4 Dyne Therapeutics, Inc. For: Dec 11 Filed by: Beskrovnaya Oxana
12/11
08:41 pm
dyn
Form 4 Dyne Therapeutics, Inc. For: Dec 11 Filed by: Scalzo Richard William
Medium
Report
Form 4 Dyne Therapeutics, Inc. For: Dec 11 Filed by: Scalzo Richard William
12/11
04:20 pm
dyn
Form 144 Dyne Therapeutics, Inc. Filed by: HIGH SUSANNA GATTI
Medium
Report
Form 144 Dyne Therapeutics, Inc. Filed by: HIGH SUSANNA GATTI
12/11
04:19 pm
dyn
Form 144 Dyne Therapeutics, Inc. Filed by: Beskrovnaya Oxana
Medium
Report
Form 144 Dyne Therapeutics, Inc. Filed by: Beskrovnaya Oxana
12/11
04:18 pm
dyn
Form 144 Dyne Therapeutics, Inc. Filed by: Scalzo Richard William
Medium
Report
Form 144 Dyne Therapeutics, Inc. Filed by: Scalzo Richard William
12/10
04:05 pm
dyn
Form 4 Dyne Therapeutics, Inc. For: Dec 06 Filed by: Kersten Dirk
Medium
Report
Form 4 Dyne Therapeutics, Inc. For: Dec 06 Filed by: Kersten Dirk
12/6
04:06 pm
dyn
Form 4 Dyne Therapeutics, Inc. For: Dec 04 Filed by: Kerr Douglas
Low
Report
Form 4 Dyne Therapeutics, Inc. For: Dec 04 Filed by: Kerr Douglas
12/6
04:06 pm
dyn
Form 4 Dyne Therapeutics, Inc. For: Dec 04 Filed by: Kersten Dirk
Low
Report
Form 4 Dyne Therapeutics, Inc. For: Dec 04 Filed by: Kersten Dirk
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: